Compare VEEV & LVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VEEV | LVS |
|---|---|---|
| Founded | 2007 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Hotels/Resorts |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.3B | 31.2B |
| IPO Year | 2013 | 2004 |
| Metric | VEEV | LVS |
|---|---|---|
| Price | $192.50 | $45.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 14 |
| Target Price | ★ $280.42 | $69.21 |
| AVG Volume (30 Days) | 1.9M | ★ 4.0M |
| Earning Date | 05-27-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.23% |
| EPS Growth | ★ 25.93 | 19.90 |
| EPS | ★ 1.57 | 0.85 |
| Revenue | $1,104,081,000.00 | ★ $13,017,000,000.00 |
| Revenue This Year | $14.42 | $7.24 |
| Revenue Next Year | $12.17 | $4.49 |
| P/E Ratio | $125.77 | ★ $53.78 |
| Revenue Growth | ★ 28.05 | 15.22 |
| 52 Week Low | $148.05 | $44.22 |
| 52 Week High | $310.50 | $70.45 |
| Indicator | VEEV | LVS |
|---|---|---|
| Relative Strength Index (RSI) | 62.39 | 39.95 |
| Support Level | $151.71 | N/A |
| Resistance Level | $202.59 | $54.58 |
| Average True Range (ATR) | 6.61 | 1.06 |
| MACD | 0.49 | 0.11 |
| Stochastic Oscillator | 68.39 | 43.24 |
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, Sands generates all its EBITDA from Asia, with its casino operations generating the majority of sales.